Form 4: Johnson & Johnson Executive Sells Shares
Insider Transaction (Form 4)
Jennifer L Taubert, EVP, WWC. Innovative Medicine of Johnson & Johnson, sold 15,000 shares of common stock on August 17, 2026 for $263.36 per share.
Summary
- Option exercise/conversion: acquired 15,000 Common Stock at $115.67 ($1,735,050) on August 17, 2026; holds 209,451 after (Direct).
- Open-market sale: disposed of 15,000 Common Stock at $263.36 ($3,950,400) on August 17, 2026; holds 194,451 after (Direct).
- Option exercise/conversion: disposed of 15,000 Employee Stock Options (Right to Buy) on August 17, 2026; holds 28,712 after (Direct).
Sentiment
Score: 3
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $3,950,400 of stock on the open market.
Insider Transactions
Jennifer L Taubert — Officer (EVP, WWC. Innovative Medicine)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-17 | Option exercise/conversion | Common Stock | 15,000 | $116 | $1.7M | 209,451.001 |
| 2026-08-17 | Open-market sale | Common Stock | 15,000 | $263 | $4.0M | 194,451.001 |
| 2026-08-17 | Option exercise/conversion | Employee Stock Options (Right to Buy) | 15,000 | — | — | 28,712 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-17 | Option exercise/conversion (15,000 shares) |
| 2026-08-17 | Open-market sale (15,000 shares) |
| 2026-08-17 | Option exercise/conversion (15,000 shares) |
Keywords
insider transaction, Form 4, JNJ, JOHNSON & JOHNSON, bearish, Jennifer L Taubert
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.